Medically Reviewed Content
Written by Rob Anderson, Health Technology Researcher & Medical Content Specialist. This article is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting any medication.
Ozempic was already known to protect the heart. In 2024, landmark trial data established it also meaningfully protects the kidneys — making semaglutide one of the few medications with proven benefits across weight, blood sugar, cardiovascular, and kidney outcomes simultaneously.
The FLOW Trial: What It Showed
The FLOW trial (Semaglutide in Patients with Chronic Kidney Disease) enrolled over 3,500 people with type 2 diabetes and chronic kidney disease (CKD stages 2–4). At 3.4 years of follow-up, semaglutide reduced the primary composite kidney outcome (major sustained eGFR decline, kidney failure, or kidney/cardiovascular death) by 24% compared to placebo. The trial was stopped early because the benefit was so clear. This led directly to the FDA approving Ozempic for an additional indication: reducing the risk of worsening kidney disease and cardiovascular events in adults with T2D and CKD.
How Semaglutide Protects the Kidneys
GLP-1 receptors are present throughout the kidney. Semaglutide appears to protect kidneys through several mechanisms: reducing glomerular hyperfiltration (the initial over-working of kidney filters that accelerates damage), reducing kidney inflammation and oxidative stress, lowering blood pressure (both directly and through weight loss), improving blood sugar control which slows diabetic nephropathy, and reducing proteinuria — the protein leaking into urine that marks kidney damage progression.
Who Benefits Most
The clearest kidney benefit is in people with type 2 diabetes and established chronic kidney disease. For this population, semaglutide now has two major organ-protection indications: cardiovascular (from SUSTAIN-6/SELECT) and kidney (from FLOW). For non-diabetic people with kidney disease, evidence is much more limited and this is not a current approved indication.
Semaglutide and Kidney Function Tests
Some patients starting semaglutide notice a temporary slight increase in serum creatinine or decrease in eGFR in the first few weeks. This is generally a benign, transient change related to reduced hyperfiltration — actually indicating the kidney is under less strain — and not a sign of damage. It typically normalises and should be interpreted in clinical context by your physician rather than causing alarm.
Frequently Asked Questions
Q: Does Ozempic protect the kidneys?
A: Yes. The FLOW trial (2024) showed semaglutide reduced the risk of major kidney disease events by 24% and slowed the rate of kidney function decline in people with type 2 diabetes and chronic kidney disease. The FDA approved an expanded indication for kidney protection in 2024.
Q: Can Ozempic be used with kidney disease?
A: Yes, with caution. Semaglutide can be used in mild-to-moderate chronic kidney disease. It is not primarily cleared by the kidneys, so dose adjustment is not required based on kidney function alone. Severe kidney disease or dialysis requires careful physician assessment.
Q: How does semaglutide help the kidneys?
A: Semaglutide reduces kidney inflammation, lowers blood pressure, improves glucose control (which prevents diabetic nephropathy progression), and reduces proteinuria (protein in urine — a marker of kidney damage). The combination of these effects produces meaningful kidney protection in high-risk patients.
📖 Further Reading
Explore Physician-Supervised Semaglutide Today
Physician-supervised compounded semaglutide from $149/month. No insurance required.
Sponsored | Affiliate link
Practical Steps to Support Kidney Health While on Semaglutide
Beyond the clinical benefits demonstrated in the FLOW trial, there are practical steps you can take to maximize kidney health while using semaglutide. Staying well-hydrated is essential since dehydration from reduced food intake or GI side effects like diarrhea can strain the kidneys. Aim for at least eight glasses of water daily and monitor urine color as a simple hydration gauge. Regular monitoring of kidney function through blood tests (eGFR and creatinine) and urine albumin levels helps track progress. Limiting sodium intake to under 2,300 mg per day also reduces kidney workload significantly.
Affiliate disclosure: This article contains affiliate links. See our Affiliate Disclosure.
Sources & References
- U.S. Food and Drug Administration (FDA) – Drug Approvals and Databases
- National Institutes of Health (NIH) – PubMed Medical Literature
- American Diabetes Association – Medication & Therapies
- Novo Nordisk – Clinical Research Data
- Eli Lilly – Medical Information
This content is regularly reviewed and updated to reflect the latest medical research and FDA guidance.